DMVT 506
Alternative Names: DMVT-506Latest Information Update: 12 Nov 2024
Price :
$50 *
At a glance
- Originator Dermavant Sciences
- Class Anti-inflammatories; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Aryl hydrocarbon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Immunological disorders; Inflammation
Most Recent Events
- 28 Oct 2024 Dermavant Sciences has been acquired by Organon
- 14 Jul 2022 Preclinical trials in Immunological disorders in USA (Topical) (Dermavent Sciences pipeline- July 2022)
- 14 Jul 2022 Preclinical trials in Inflammation in USA (Topical) (Dermavent Sciences pipeline- July 2022)